Health

Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics

CALGARY, AB and TORONTO, May 23, 2024 /PRNewswire/ -- Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario Institute for Cancer Research (OICR),Ontario's largest...

2024-05-23 21:05 1345

Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters

SAN JOSE, Calif., May 23, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, recently welcomed vendors, suppliers, customers and employees to aMay 17 grand opening celebration of its 10,115 square foot manufacturing facility at its headquarters inSan Jose, California...

2024-05-23 21:00 1498

Vatech Partners with Tygerberg Public Hospital to Improve Dental Care in South Africa

SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- Vatech, a global leader in the dental imaging market, is launching a project to improve dental healthcare in South Africa. Vatech announced today that it has partnered with Tygerberg Hospital inCape Town, South Africa to donate medical equipment for...

2024-05-23 21:00 1691

Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer

SHANGHAI and WARREN, N.J., May 23, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food and Drugs Administration for the protocol of the phase III clinical trial of LAE002 (afureser...

2024-05-23 20:42 1820

Guo Guangchang: Fosun Steadfastly Focuses on Innovation + Globalization

HONG KONG, May 23, 2024 /PRNewswire/ -- The 4th BEYOND International Technology Innovation Expo (BEYOND Expo 2024) commenced with a spectacular opening ceremony on 22 May at the Venetian Theatre in the Venetian Macao. At the opening ceremony, Guo Guangchang, Chairman of Fosun International, said ...

2024-05-23 18:31 3944

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

AMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development (R&D), including investment in access and stewardship planning...

2024-05-23 18:00 1728

111, Inc. Announces First Quarter 2024 Unaudited Financial Results

* Turned to Quarterly Operational Profitability for the First Time * Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% * Achieved Positive Operating Cash Flow SHANGHAI, May 23, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading...

2024-05-23 16:43 3459

Manulife Launches a Two-Year Strategic Charity Partnership with Mind HK

Key initiatives aim to address misconceptions towards mental health and empower sustained health and well-being                            HONG KONG, May 23, 2024 /PRNewswire/ -- Manulife Hong Kong today announced a two-year strategic partnership with Mind HK, aHong Kong-based mental health char...

2024-05-23 14:06 3456

Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur

Advanced TAVI Procedure on Patient with Severe Aortic Stenosis KUALA LUMPUR, Malaysia, May 23, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL), a leader in medical excellence and patient care, has achieved another significant medical milestone with the successful launch of its Transcath...

2024-05-23 11:22 11995

MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship

SINGAPORE, May 23, 2024 /PRNewswire/ -- MediThinQ, the Korean startup pioneering extended reality (XR) wearable displays for surgical applications, unveils its groundbreaking SCOPEYE 3D Micro Surgery Solution. This innovative microsurgery solution leverages the latest Eyes Up Display technology t...

2024-05-23 10:00 14085

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024

* Presentation at ARVO 2024 gained attention as Eylea (aflibercept) eye drops demonstrated similar efficacy to intravitreal injections in animal studies. DAEJEON, South Korea , May 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ:208340), a clinical-stage publ...

2024-05-23 08:51 1565

Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference

Corporate presentation scheduled for Tuesday, 04 June 2024 at 4:00 PM PT SAN DIEGO and SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- Bionoxx Inc., an innovative biotech company developing neutrophil-directed T cell modulation technology, announced today it will unveil its novel immunomodulator...

2024-05-23 08:00 1931

Further CYP-001 GvHD Clinical Data Published in Nature Medicine

Two-year overall survival rate in patients with steroid-resistant acute GvHD was 60% MELBOURNE, Australia, May 23, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to an...

2024-05-23 07:53 1649

Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

CAMBRIDGE, Mass., May 22, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a license agreemen...

2024-05-23 07:23 1450

Smartee Empowers the Next Generation of Orthodontists at the 2nd HADO Exhibition

BUDAPEST, Hungary, May 22, 2024 /PRNewswire/ -- On May 20, 2024, Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, presented its innovative Smartee GS Mandibular Repositioning Technology at the 2nd HADO Exhibition, held from May 16-19, 2024 in Budapest...

2024-05-22 22:46 1578

Aiming for New Quality Productivity, Aiding in Reaching the Summit of Global Innovative Pharmaceuticals

Fully Human Antibody Development Platform—NeoMab Bio Officially Opens in Suzhou SUZHOU, China, May 22, 2024 /PRNewswire/ -- On May 22, 2024, NeoMab Biotechnology (Suzhou) Co., Ltd. celebrated its grand opening in Suzhou Industrial Park (BioBAY). This marks a significant milestone that will furthe...

2024-05-22 22:38 1874

Bumrungrad International Hospital Achieves GHA Accreditation with "Excellence," Demonstrating its Global Leadership Position in Medical Tourism

PALM BEACH GARDENS, Fla., May 22, 2024 /PRNewswire/ -- Bumrungrad International Hospital recently earned its third Global Healthcare Accreditation (GHA)  "Accreditation with Excellence," scoring 100% across all criteria measuring the quality of care delivered to medical tourists. Bumrungrad Intern...

2024-05-22 21:21 2387

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

SEOUL, South Korea, May 22, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of its acquisition of Volpara Health Technologies, a global leader in medical software for breast...

2024-05-22 21:00 2059

GV Announces Cooperation with CICC

TORONTO, May 22, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company's subordina...

2024-05-22 20:30 2726

I-Mab to Participate at the Jefferies Global Healthcare Conference

ROCKVILLE, Md., May 22, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the ...

2024-05-22 19:00 1388
1 ... 81828384858687 ... 858